Fluxome US: “Business as usual” despite euro crisis

By Shane Starling

- Last updated on GMT

Fluxome US: “Business as usual” despite euro crisis

Related tags: Venture capital

The US operation of financially stricken resveratrol supplier, Fluxome, says the cash crisis that has forced closure of its Danish research facility, will not halt resveratrol supply through its US operation.

In a statement, the US arm of the company said the closure was necessary to preserve the US operation as firm awaits potential investment lifelines around IP for a long-running yeast-derived omega-3 project.

“[The closure] was taken in part to preserve assets for its US commercial operations for the production and selling of resveratrol,”​ Fluxome Inc. [US] said.

“At this time, the Danish facility has closed its research activities during this reconstruction phase. Fluxome A/S [Denmark], while in reconstruction, is in the process of obtaining additional funding to continue its operations both here and abroad and/or a sale of its assets.”

“In the meantime, it is business as usual for the resveratrol operation and customers should not notice any disruption in supply.”

The closure saw 21 people sacked last week without notice or pay for September as the company filed for a “formal reconstruction”​ in Danish courts. That matter is set to be heard on October 22.

One observer close to the situation said it was a direct result of mismanagement and overspending on new staff and facilities, while the company said it was precipitated by the last-minute withdrawal of an investor.

Chairman Jarne Elleholm said 3-4 parties - industry players and venture capitalists - had expressed strong interest in taking a share in investing in the omega-3 research project that employed about 15 people until last week.

Fluxome is owned by venture capital firms based in Belgium, France and Denmark.

Related news

Show more

Related products

show more

Master Immune Health with the Master Antioxidant

Master Immune Health with the Master Antioxidant

Kyowa Hakko Europe GmbH | 15-Sep-2021 | Product Brochure

With increased consumer demand for immune health supplements, ingredients with antioxidant properties have consequently experienced increased demand. One...

Reach Consumers with Fruit & Vegetable Powders

Reach Consumers with Fruit & Vegetable Powders

vaneeghen | 08-Sep-2021 | Technical / White Paper

Are you looking to create products that appeal to today’s plant-forward consumers? The plant-based revolution continues to captivate the market as consumers...

Turmacin®: Clean Label & Clinically Tested Turmeric

Turmacin®: Clean Label & Clinically Tested Turmeric

Natural Remedies Private Limited | 01-Sep-2021 | Product Presentation

Turmacin® is a clean label project-certified, clinically tested, and clinically safe turmeric extract. Turmacin® is rich in Turmerosaccharides® and doesn't...

Quatrefolic®: The Active folate vs Folic Acid

Quatrefolic®: The Active folate vs Folic Acid

Gnosis by Lesaffre USA | 31-Aug-2021 | Infographic

Folate deficiency concerns everyone at every step of their life. The supplementation of vitamin B9 is often be misunderstood, especially regarding the...

Related suppliers

Follow us

Products

View more

Webinars